/

Early Value Assessment

Unlock Your Potential with Early Value Assessment (EVA)

EVA can help you identify value drivers that contribute to commercial success, prioritise assets for maximum return on investment and make informed strategic decisions throughout the development process.

Conduct a landscape assessment on relevant HTA successes for the asset and therapeutic area.
Develop an early model to understand the cost-effectiveness and economically justifiable pricing.
Consolidate findings into actionable recommendations.

We look forward to helping you achieve your product objectives and business goals.

Get in touch

Three-phased approach

Our three-phased approach ensures that each EVA is tailored to your specific needs. The phases include:

Strategy

Kick-off meeting
Data deep-dive
EVA model development using FIECON's innovative blend of qualitative and quantitative analysis.
Ideation workshop
Development of an EVA specification document.
Project management, strategic guidance, and regular communication throughout all phases.
EVA specification document

EVA Modelling

EVA Model
Linked forecast model
Linked forecast model that explores the impact of scenarios with regards to budget and return on investment or revenues.
Consider trade-offs between price, volume, and later launches with longer clinical development, while factoring in risk.

Results

Results page including RAG scores and ROI
Strategic recommendations for asset prioritisation
Interactive HTML results dashboard
Update EVA specification document

Example outputs

Our Excel models deliver key insights for strategic decision-making, including economically justifiable pricing, key value drivers, product vs. comparator analysis, and HTA success likelihood

Our Interactive HTML Results Dashboard showcases dynamic insights into your product’s likelihood of approval.

Customise commercial drivers such as molecule, market, and economic factors to see how they impact approval chances. Simultaneously, view the potential pricing corridor and operating profit margins.

Key Benefits

Establish an overall likelihood of HTA success

Strategic Decision-Making

Models guide resource allocation and prioritise development efforts by assessing cost-effectiveness and market viability.

Identification of Evidence Gaps

We highlight data gaps, directing future research and evidence generation.

Risk Mitigation

Early insights help address potential challenges, reducing late-stage failures.

HTA Strategy

We identify factors influencing reimbursement, such as cost-effectiveness, therapeutic value, and qualitative aspects like disease burden.

Application of RAG status

Using the RAG status in early economic models allows for a comprehensive evaluation of the potential of the asset.

Areas needing further evidence generation and strategic priorities are highlighted to enhance the likelihood of HTA success. This holistic approach ensures that all critical factors influencing reimbursement decisions are considered, providing a robust framework for pipeline asset evaluation.

What are RAG Scores?

RAG scores are used to indicate the likelihood of success or failure of an asset in a specific domain. This holistic approach ensures that all critical factors influencing reimbursement decisions (e.g. Affordability, Therapeutic value and Qualitative aspects) are considered, providing a robust framework for pipeline asset evaluation.

Digital Innovation for Strategic Success

At FIECON, we use advanced technology, and AI to enhance the quality of our health economics and market access strategies. By automating processes and improving data analysis, we deliver precise, tailored solutions that optimize product commercialization and ensure strategic success.

Technology

We leverage bespoke technology to enhance the accuracy and efficiency of our economic modelling and statistical analysis. Tailored to our clients' needs, ensuring our analyses are high quality and resonate with stakeholders and drive successful outcomes.

Private AI Platform

Our tailored, private LLM platform enables us to use AI as a human copilot, enhancing decision-making while ensuring data privacy in a secure environment. This approach streamlines processes and delivers precise, data-driven solutions, allowing our experts to focus on delivering high-quality strategic advice.

Get in touch

Get a completely free, no-obligation opportunity to discuss your needs and see how we can boost your business.

Brainstorm solutions to key challenges with experienced team
Validate your strategy and value evidence
Learn more about FIECON’s products and key areas of expertise and discuss opportunities for collaboration

Thank you!

We received your details. Someone from our team will contact you soon.

Oops!

Something went wrong while submitting the form.

Unlock Your Potential with Early Value Assessment (EVA)

EVA can help you identify value drivers that contribute to commercial success, prioritise assets for maximum return on investment and make informed strategic decisions throughout the development process.

Three-phased approach

Strategy

Kick-off meeting

Data deep-dive

Ideation workshop

EVA specification document

EVA Modelling

EVA Model

Linked forecast model

Results

Results page including RAG scores and ROI

Strategic recommendations for asset prioritisation

Interactive HTML results dashboard

Update EVA specification document

Example outputs

Our Excel models deliver key insights for strategic decision-making, including economically justifiable pricing, key value drivers, product vs. comparator analysis, and HTA success likelihood

Our Interactive HTML Results Dashboard showcases dynamic insights into your product’s likelihood of approval.

Key Benefits

Strategic Decision-Making

Identification of Evidence Gaps

Risk Mitigation

HTA Strategy

Application of RAG status

Using the RAG status in early economic models allows for a comprehensive evaluation of the potential of the asset.

What are RAG Scores?

Similar solutions

Early modelling to support pricing and HTA

Go/No-go assessment for pipeline products

Build models faster, with fewer errors

Digital Innovation for Strategic Success

Technology

Private AI Platform

Get in touch

Your contact details

Thank you!

Oops!

Unlock Your Potential with Early Value Assessment (EVA)

EVA can help you identify value drivers that contribute to commercial success, prioritise assets for maximum return on investment and make informed strategic decisions throughout the development process.

Three-phased approach

Strategy

Kick-off meeting

Data deep-dive

Ideation workshop

EVA specification document

EVA Modelling

EVA Model

Linked forecast model

Results

Results page including RAG scores and ROI

Strategic recommendations for asset prioritisation

Interactive HTML results dashboard​

Update EVA specification document

Example outputs

Our Excel models deliver key insights for strategic decision-making, including economically justifiable pricing, key value drivers, product vs. comparator analysis, and HTA success likelihood

Our Interactive HTML Results Dashboard showcases dynamic insights into your product’s likelihood of approval.

Key Benefits

Strategic Decision-Making

Identification of Evidence Gaps

Risk Mitigation

HTA Strategy

Application of RAG status

Using the RAG status in early economic models allows for a comprehensive evaluation of the potential of the asset.

What are RAG Scores?

Similar solutions

Early modelling to support pricing and HTA

Go/No-go assessment for pipeline products

Build models faster, with fewer errors

Digital Innovation for Strategic Success

Technology

Private AI Platform

Get in touch

Your contact details

Thank you!

Oops!

Thank you for your subscription!

Oops...

Interactive HTML results dashboard